Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation.

Verger E, Teillet F, Conejero C, Letort G, Chomienne C, Giraudier S, Cassinat B.

Br J Haematol. 2016 Oct;175(1):167-9. doi: 10.1111/bjh.13840. Epub 2015 Nov 16. No abstract available.

PMID:
26568271
2.

[Palliative care day hospital and nursing coordination].

Teillet F.

Soins. 2015 Nov;(800):39-40. doi: 10.1016/j.soin.2015.09.009. French.

PMID:
26567073
3.

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.

Khellaf M, Charles-Nelson A, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Ebbo M, Le Guenno G, Cliquennois M, Salles G, Bonmati C, Teillet F, Galicier L, Hot A, Lambotte O, Lefrère F, Sacko S, Kengue DK, Bierling P, Roudot-Thoraval F, Michel M, Godeau B.

Blood. 2014 Nov 20;124(22):3228-36. doi: 10.1182/blood-2014-06-582346. Epub 2014 Oct 7.

4.

[An uncommon etiology of anemia: copper deficiency].

Kouamou E, Stépanian A, Khadra F, de Prost D, Teillet F.

Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):481-4. doi: 10.1684/abc.2013.0863. French.

5.

The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin.

Gaboriaud C, Gupta RK, Martin L, Lacroix M, Serre L, Teillet F, Arlaud GJ, Rossi V, Thielens NM.

PLoS One. 2013 Jul 4;8(7):e67962. doi: 10.1371/journal.pone.0067962. Print 2013.

6.

Antitumoral activity of allosteric inhibitors of protein kinase CK2.

Moucadel V, Prudent R, Sautel CF, Teillet F, Barette C, Lafanechere L, Receveur-Brechot V, Cochet C.

Oncotarget. 2011 Dec;2(12):997-1010.

7.

Structure and properties of the Ca(2+)-binding CUB domain, a widespread ligand-recognition unit involved in major biological functions.

Gaboriaud C, Gregory-Pauron L, Teillet F, Thielens NM, Bally I, Arlaud GJ.

Biochem J. 2011 Oct 15;439(2):185-93. doi: 10.1042/BJ20111027. Review.

PMID:
21954942
8.

Ischaemic colitis associated with JAK2V617F mutation.

Barbieri J, Duboc H, Teillet F, Sabate JM, Peynaud E, Jouet P, Coffin B.

Gut. 2012 May;61(5):784-5. doi: 10.1136/gutjnl-2011-300396. Epub 2011 Jul 8. No abstract available.

PMID:
21742745
9.

Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonist.

Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N.

J Med Chem. 2010 Jun 10;53(11):4428-40. doi: 10.1021/jm1002167.

PMID:
20462213
10.

Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins.

Teillet F, Gaboriaud C, Lacroix M, Martin L, Arlaud GJ, Thielens NM.

J Biol Chem. 2008 Sep 12;283(37):25715-24. doi: 10.1074/jbc.M803551200. Epub 2008 Jul 2.

11.

Flavonoids as RTK inhibitors and potential anticancer agents.

Teillet F, Boumendjel A, Boutonnat J, Ronot X.

Med Res Rev. 2008 Sep;28(5):715-45. Review.

PMID:
18080331
12.

Assembly of C1 and the MBL- and ficolin-MASP complexes: structural insights.

Gaboriaud C, Teillet F, Gregory LA, Thielens NM, Arlaud GJ.

Immunobiology. 2007;212(4-5):279-88. Epub 2006 Dec 20. Review.

PMID:
17544813
13.

Identification of the site of human mannan-binding lectin involved in the interaction with its partner serine proteases: the essential role of Lys55.

Teillet F, Lacroix M, Thiel S, Weilguny D, Agger T, Arlaud GJ, Thielens NM.

J Immunol. 2007 May 1;178(9):5710-6.

15.
16.

[Macrophage activation syndrome, hemophagocytic syndrome].

Pradalier A, Teillet F, Molitor JL, Drappier JC.

Pathol Biol (Paris). 2004 Sep;52(7):407-14. Review. French.

PMID:
15336434
17.

Pleomorphic medium-sized T-cell lymphoma following Hodgkin's disease (nodular sclerosis type).

Gaulier A, Teillet F, Davi F, Couturier J, Laye S, Raphael M.

Arch Pathol Lab Med. 1997 Apr;121(4):411-6. Review.

PMID:
9140313
18.

[Relapsing polychondritis, thrombosis and antiphospholipid antibodies].

Grasland A, Pouchot J, Teillet-Thiebaud F, Teillet F, Guillevin L, Vinceneux P.

Rev Med Interne. 1996;17(3):231-3. French.

PMID:
8734145
19.

Cardiac localization of non-Hodgkin's lymphoma: two case reports and review of the literature.

Delmas-Marsalet B, Molinie V, Jary L, Teillet-Thiebaud F, Estagnasie P, Barge J, Teillet F.

Nouv Rev Fr Hematol. 1995;37(4):223-30. Review.

PMID:
8904202
20.

[Varicella-zoster virus pancreatitis in hematologic diseases].

Pulik M, Teillet F, Teillet-Thiebaud F, Lionnet F, Genet P, Petitdidier C.

Ann Med Interne (Paris). 1995;146(5):292-4. Review. French.

PMID:
8526311
21.

Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature.

Delmas-Marsalet B, Beaulieu P, Teillet-Thiebaud F, Jary L, Teillet F.

Nouv Rev Fr Hematol. 1995;37(3):205-10. Review.

PMID:
7567439
22.

Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.

Delva L, Cornic M, Balitrand N, Guidez F, Micléa JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, et al.

Blood. 1993 Oct 1;82(7):2175-81.

23.

[Non-Hodgkin's lymphoma associated with scleroderma].

Pulik M, Teillet-Thiebaud F, Mahe A, Teillet F.

Presse Med. 1991 Oct 5;20(31):1513-4. French. No abstract available. Erratum in: Presse Med 1991 Oct 26;20(34):1690.

PMID:
1835052
24.

[Value of the combination of interferon alpha with hydroxyurea in essential thrombocythemia].

Pulik M, Teillet F.

Presse Med. 1991 Sep 28;20(30):1458. French. No abstract available.

PMID:
1835035
25.

Association between leukemic erythroid progenitors and bone marrow macrophages.

Breton-Gorius J, Vuillet-Gaugler MH, Coulombel L, Guichard J, Teillet F, Vainchenker W.

Blood Cells. 1991;17(1):127-42; discussion 142-6.

PMID:
2018849
26.

Expression of platelet glycoproteins by erythroid blasts in four cases of trisomy 21.

Debili N, Kieffer N, Mitjavila MT, Villeval JL, Guichard J, Teillet F, Henri A, Clemetson KJ, Vainchenker W, Breton-Gorius J.

Leukemia. 1989 Sep;3(9):669-78.

PMID:
2527326
27.

[Malignant histiocytofibroma and Hodgkin's disease].

Pulik M, Teillet Thiebaud F, Teillet F.

Presse Med. 1987 Oct 24;16(35):1760. French. No abstract available.

PMID:
2827143
28.

High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

Philip T, Dumont J, Teillet F, Maraninchi D, Gorin NC, Kuentz M, Harousseau JL, Marty M, Pinkerton R, Herve P.

Br J Cancer. 1986 Jun;53(6):737-42.

29.

Autologous bone marrow transplantation in Hodgkin's disease.

Dumont J, Teillet F.

Rev Fr Transfus Immunohematol. 1985 Nov;28(5):531-8. No abstract available.

PMID:
2419958
30.

Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.

Ferme C, Teillet F, d'Agay MF, Gisselbrecht C, Marty M, Boiron M.

Cancer. 1984 Dec 1;54(11):2324-9.

PMID:
6388801
31.

Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.

Bayle-Weisgerber C, Lemercier N, Teillet F, Asselain B, Gout M, Schweisguth O.

Cancer. 1984 Jul 15;54(2):215-22.

PMID:
6547073
32.

[Hodgkin's disease: analysis of a reduction of chemotherapy].

Fermé C, Teillet F, D'Agay MF, Boiron M.

Presse Med. 1983 Sep 24;12(33):2031-4. French.

PMID:
6226016
33.

[Is exploratory laparotomy with splenectomy still indicated in Hodgkin's disease?].

Ferme C, Teillet F.

Presse Med. 1983 Feb 5;12(5):271-2. French. No abstract available.

PMID:
6220383
34.

[Surgical aspects of radiolesions of the small intestine after total lymphoid irradiation. Apropos of 19 cases].

Viandier A, Clot P, Teillet F, Bayle-Weisgerber C, Douard MC, Alhomme P.

Ann Chir. 1983 Feb;37(1):5-7. French. No abstract available.

PMID:
6847104
35.

[Malignant lymphomas and sarcoidosis (author's transl)].

Casassus P, Vannetzel JM, Experton B, Valeyre D, Brun B, Teillet F, Turpin F, Lortholary P, Battesti JP.

Nouv Presse Med. 1982 Jul 3;11(31):2339-42. French.

PMID:
6213932
36.

[Effects of mantle-field irradiation and chemotherapy on respiratory function (author's transl)].

Dixsaut G, Teillet F, Dana M, Miot C, Catherine N, Teillet-Thiebaud F.

Nouv Presse Med. 1982 Feb 6;11(6):429-32. French.

PMID:
7063379
37.

[Hodgkin disease: clinical aspects, diagnosis and study of spread].

Teillet F, Bayle-Weisgerber C, Katz M, Clot P.

Soins. 1981 May 5;26(9):6-12. French. No abstract available.

PMID:
6910833
38.

[Hodgkin disease: general aspects].

Teillet F.

Soins. 1981 May 5;26(9):3-5. French. No abstract available.

PMID:
6910829
39.

["Recovery" from Hodgkin disease].

Teillet F.

Soins. 1981 May 5;26(9):27-9. French. No abstract available.

PMID:
6910828
40.

[Hodgkin disease: results of treatment: monitoring of the patient].

Teillet-Thiebaud F, Dusapin M, Teillet F.

Soins. 1981 May 5;26(9):20-2. French. No abstract available.

PMID:
6910826
41.

[Treatment of Hodgkin disease].

Teillet F, Miot C, Bayle-Weisgerber C, Clot P, Lemercier N.

Soins. 1981 May 5;26(9):13-9. French. No abstract available.

PMID:
6910824
42.

[Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)].

Teillet F, Delbrück H, Bayle-Weisgerber C, Asselain B, Lelièvre P, Bernard J.

Dtsch Med Wochenschr. 1981 May 1;106(18):566-70. German.

PMID:
7215184
43.

[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].

Andrieu JM, Asselain B, Bayle C, Teillet F, Clot P, Dana M, Katz M, Brière J, Jacquillat C, Bernard J.

Bull Cancer. 1981;68(2):190-9. French. No abstract available.

PMID:
7016225
44.

Chemotherapy--radiotherapy association in Hodgkin's disease, clinical stages IA, II2A: results of a prospective clinical trial with 166 patients.

Andrieu JM, Montagnon B, Asselain B, Bayle-Weisgerber C, Chastang C, Teillet F, Bernard J.

Cancer. 1980 Nov 15;46(10):2126-30.

PMID:
7427857
45.

["Transparent circles" lymph glands: an unusual appearance on lymphography in certain proliferative lymphoid syndromes: prognostic value].

Katz M, Tristant H, Laval-Jeantet M, Dumont J, Bayle-Weisgerber C, Teillet F.

J Radiol. 1980 Aug-Sep;61(8-9):531-6. French.

PMID:
7463397
46.
47.

[Angio-immunoblastic lymphadenopathy : radiological study of 11 cases (author's transl)].

Cartal P, Benacerraf R, Teillet F, Katz J, Laval-Jeantet M.

Ann Radiol (Paris). 1979 Nov;22(7):555-62. French. No abstract available.

PMID:
525960
48.

[Possibilities of treatment reduction in Hodgkin's disease (author's transl)].

Teillet F, Delbrück H, Bayle-Weisgerber C, Andrieu JM, Clot P.

Dtsch Med Wochenschr. 1979 Oct 5;104(40):1405-9. German.

PMID:
498955
49.

[Haematologic disorders in Crohn's disease (author's transl)].

Teillet F, Preel JL, Hardouin JP, Debray C.

Sem Hop. 1979 Mar 18-25;55(1112):560-3. French.

PMID:
224471
50.

The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.

Andrieu JM, Bayle-Weisgerber C, Boiron M, Briere JF, Clot P, Dana M, Jacquillat C, Katz M, Teillet F.

Eur J Cancer. 1979 Feb;15(2):153-61. No abstract available.

PMID:
374084

Supplemental Content

Loading ...
Support Center